Norden Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Norden Group's WST Position: Q3 2026 in Review
Norden Group reduced its West Pharmaceutical (WST) stake by 2.2% in Q3 2026, selling an estimated $26.5K and leaving 3,334 shares worth $1.24M. The position accounts for 0.09% of the portfolio, ranked #176.
Norden Group first reported a position in WST in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.87M in Q4 2024. 273 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Norden Group held 3,334 shares of West Pharmaceutical worth $1.24M as of Q3 2026.
- Norden Group sold 75 West Pharmaceutical shares in Q3 2026, an estimated $26.5K.
- West Pharmaceutical made up 0.09% of Norden Group's portfolio in Q3 2026, its #176 holding.
- Norden Group first reported a position in West Pharmaceutical in Q3 2023 and has held it in 13 quarters since.
- Norden Group's West Pharmaceutical position peaked at $1.87M in Q4 2024.
- 273 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Norden Group's 13F filing for Q3 2026, filed 20 Oct 2026.